Business

Alliance for Building Better Medicine and the Virginia Innovation Partnership Celebrate $120 Million Investment from AstraZeneca, Eli Lilly, and Merck to Advance Virginia's Advanced Pharmaceutical Manufacturing Workforce

The Alliance for Building Better Medicine (ABBM) and the Virginia Innovation Partnership Corporation (VIPC) celebrated Governor Glenn Youngkin's announcement of $120 million in private industry investment from AstraZeneca, Eli Lilly, and Merck to establish the Virginia Center for Advanced Pharmaceutical Manufacturing (APM) in the Richmond-Petersburg-Charlottesville region. This neutral, industry-led Center will expand Virginia's workforce and training pipeline in collaboration with university an

articleAstrazeneca PlcNovember 5, 20254/company/astrazeneca-plc/news/alliance-for-building-better-medicine-and-the-virginia-innovation-partnership-celebrate-dollar120-million-investment-from-astrazeneca-eli-lilly-and-merck-to-advance-virginias-advanced-pharmaceutical-manufacturing-workforce-4
Alliance for Building Better Medicine and the Virginia Innovation Partnership Celebrate $120 Million Investment from AstraZeneca, Eli Lilly, and Merck to Advance Virginia's Advanced Pharmaceutical Manufacturing Workforce

About this update from Astrazeneca Plc

[{"type":"text","content":"RICHMOND, Va., Nov. 5, 2025 /PRNewswire/ -- The Alliance for Building Better Medicine (ABBM) and the Virginia Innovation Partnership Corporation (VIPC) celebrated Governor Glenn Youngkin's announcement of $120 million in private industry investment from AstraZeneca, Eli Lilly, and Merck to establish the Virginia Center for Advanced Pharmaceutical Manufacturing (APM) in the Richmond-Petersburg-Charlottesville region. This neutral, industry-led Center will expand Virginia's workforce and training pipeline in collaboration with university and community college partners to unleash the next generation of talent and innovation. This industry workforce investment follows $12.5 billion of recently announced capex investment in Virginia by these global Life Science industry leaders which will create thousands of jobs in Virginia in the coming years.","length":860,"tagName":"p"},{"type":"image","alt":"www.buildingbettermedicine.com","displaySize":"","headline":null,"caption":"www.buildingbettermedicine.com","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":86,"url":"https://media.zenfs.com/en/prnewswire.com/91231adc14cb0184f15de453f68a167f"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/E.MZH3AdEje0QeUFScHQjg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTE1MjtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/91231adc14cb0184f15de453f68a167f","width":400,"height":86}},"href":"https://mma.prnewswire.com/media/2814662/Alliance_for_Building_Better_Medicine_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"An official Memorandum of Understanding (MOU) signed by VIPC Chief Executive Officer Joe Benevento and leaders from Lilly, AstraZeneca, Merck was executed by Governor Youngkin on October 31 in Richmond. ABBM Board Chair Robby Demeria and Regional Innovation Officer Joy Polefrone attended this momentous occasion along with the President of Virginia Commonwealth University, Michael Rao, and senior leadership representatives from University of Virginia; Virginia Tech; Virginia Commonwealth University; Old Dominion University; James Madison University; and Hampton University, as well as the Virginia Community College System, including Brightpoint Community College, Reynolds Community College, Piedmont Virginia Community College, and Blue Ridge Community College.","length":768,"tagN...

More updates from Astrazeneca Plc

Virginia Innovation Partnership CorporationPharmaceutical ManufacturingVIPCVIPC Chief Executive Officer Joe BeneventoVirginiaAstraZenecathe AllianceVirginia TechUniversity of VirginiaGlenn YoungkinMerckBuilding